DK0396069T3 - Salte af azelastin med forbedret opløselighed - Google Patents

Salte af azelastin med forbedret opløselighed

Info

Publication number
DK0396069T3
DK0396069T3 DK90108172.9T DK90108172T DK0396069T3 DK 0396069 T3 DK0396069 T3 DK 0396069T3 DK 90108172 T DK90108172 T DK 90108172T DK 0396069 T3 DK0396069 T3 DK 0396069T3
Authority
DK
Denmark
Prior art keywords
azelastine
salts
improved solubility
acid
present
Prior art date
Application number
DK90108172.9T
Other languages
Danish (da)
English (en)
Inventor
Helmut Dr Hettche
Reinhard Dr Muckenschnabel
Gerhard Dr Scheffler
Fleischhauer Dr Ilona
Wolfgang Dr Morick
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0396069T3 publication Critical patent/DK0396069T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK90108172.9T 1989-05-05 1990-04-28 Salte af azelastin med forbedret opløselighed DK0396069T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3914859 1989-05-05

Publications (1)

Publication Number Publication Date
DK0396069T3 true DK0396069T3 (da) 1994-07-25

Family

ID=6380164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90108172.9T DK0396069T3 (da) 1989-05-05 1990-04-28 Salte af azelastin med forbedret opløselighed

Country Status (17)

Country Link
US (4) US5086050A (fr)
EP (1) EP0396069B1 (fr)
JP (1) JPH02295987A (fr)
AT (1) ATE107643T1 (fr)
AU (1) AU622022B2 (fr)
CA (1) CA2016089C (fr)
DD (1) DD294254A5 (fr)
DE (2) DE59006184D1 (fr)
DK (1) DK0396069T3 (fr)
ES (1) ES2055216T3 (fr)
FI (1) FI902244A0 (fr)
HU (1) HU206110B (fr)
IE (1) IE63662B1 (fr)
NO (1) NO901985L (fr)
NZ (1) NZ233546A (fr)
PT (1) PT93946B (fr)
YU (1) YU86390A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
JP4138910B2 (ja) 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
WO1999021565A1 (fr) * 1997-10-24 1999-05-06 Cornell Research Foundation, Inc. Supplement nutritionnel pour personnes atteintes d'insuffisances du metabolisme cerebral
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7694694B2 (en) * 2004-05-10 2010-04-13 The Aerospace Corporation Phase-change valve apparatuses
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2522365T (pt) 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2697662B1 (fr) 2011-04-13 2018-06-06 Codexis, Inc. Procédé biocatalytique permettant de préparer de l'eslicarbazépine et ses analogues
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (fr) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
ATE60598T1 (de) * 1985-11-11 1991-02-15 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
EP0289939A1 (fr) * 1987-05-08 1988-11-09 ASTA Pharma AG Dérivés du 4-benzyl-1-(2H)-phtalazinone avec un radical acide aminé
DE3850044D1 (de) * 1987-11-13 1994-07-14 Asta Medica Ag Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤

Also Published As

Publication number Publication date
YU86390A (en) 1992-05-28
JPH02295987A (ja) 1990-12-06
DD294254A5 (de) 1991-09-26
FI902244A0 (fi) 1990-05-04
HUT53901A (en) 1990-12-28
ATE107643T1 (de) 1994-07-15
DE4013696A1 (de) 1990-11-08
CA2016089A1 (fr) 1990-11-05
HU902678D0 (en) 1990-09-28
US5859003A (en) 1999-01-12
US5086050A (en) 1992-02-04
EP0396069A1 (fr) 1990-11-07
US5998403A (en) 1999-12-07
NO901985L (no) 1990-11-06
AU5473690A (en) 1990-11-08
AU622022B2 (en) 1992-03-26
NO901985D0 (no) 1990-05-04
DE59006184D1 (de) 1994-07-28
ES2055216T3 (es) 1994-08-16
US6017909A (en) 2000-01-25
EP0396069B1 (fr) 1994-06-22
PT93946B (pt) 1996-11-29
IE63662B1 (en) 1995-05-31
CA2016089C (fr) 1998-12-01
IE901639L (en) 1990-11-05
PT93946A (pt) 1991-01-08
NZ233546A (en) 1991-09-25
HU206110B (en) 1992-08-28

Similar Documents

Publication Publication Date Title
DK0396069T3 (da) Salte af azelastin med forbedret opløselighed
CY1105091T1 (el) Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
PT1177176E (pt) Derivados de acidos triarilicos como ligandos de receptores ppar.
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
DE69922703D1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
RO91871B (ro) Procedeu pentru prepararea unor derivati de 1,4-dihidro-4-oxonaftiridina
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
BR0211826A (pt) Imidazopiridinas tricìclicas
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
TR199800543A2 (xx) Benziloksi ikame edilen, aniliye edilmi� N-heterosiklik bile�ikler.
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
TR200102514T2 (tr) COPD tedavisi için metod
CO5160271A1 (es) Composicion de alta pureza que comprende (7 alfa, 17 alfa)- 17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona
ES2152097T3 (es) Empleo de esteres de acidos hidroxicarboxilicos como espesantes.
DK1054869T3 (da) 3,4-Dihydroquinolin-derivater som inhibitorer for nitrogenmonoxid-synthase (NOS)
DE60025644T8 (de) Hemmer für das 20-hete-produzierende enzym
PT98700A (pt) Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
SE9903345D0 (sv) Novel process
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
FI851073L (fi) Inhibitor foer dopamin- -hydroxylas.